ReadYourDNA

Meperidine (Demerol)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Meperidine

What it is

Pethidine (meperidine) is a synthetic opioid once widely used for pain, including in labour. It has largely fallen out of favour because its breakdown product norpethidine can build up and cause seizures, and it interacts dangerously with MAO inhibitors. It is still used for shivering after anaesthesia and in some countries in labour. It is sold as Demerol, among other names.

How genes come into it

Pethidine is broken down by carboxylesterases and by CYP2B6, CYP3A4 and CYP2C19, which form norpethidine. The few gene studies on it looked at CYP2C19, CYP3A5 and UGT1A1 for its levels, and at FIP1L1 and SERINC5 for side effects. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Meperidine. Upload your DNA file to see which of these rows apply to you.

Rated evidence (3 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

FIP1L1 rs113100019: Level 3. Toxicity: adverse events. 1.

SERINC5 rs185462714: Level 3. Toxicity: adverse events. 1.

rs11049274: Level 3. Toxicity: adverse events. 1.

Metabolism (3 findings)

Studies of how quickly the body processes this medication.

CYP2C19 CYP2C19 poor metabolizers and intermediate metabolizers: CYP2C19 poor metabolizers and intermediate metabolizers is associated with decreased dose of fentanyl, meperidine or midazolam in people with sedation as compared to CYP2C19 normal metabolizer.

CYP3A5 CYP3A5 poor metabolizer: CYP3A5 poor metabolizer is associated with decreased dose of fentanyl, meperidine or midazolam in people with sedation as compared to CYP3A5 intermediate metabolizer.

UGT1A1 UGT1A1 poor metabolizer: UGT1A1 poor metabolizer is associated with decreased dose of fentanyl, meperidine or midazolam in people with sedation as compared to UGT1A1 normal metabolizer.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Alfenta (Opioids)

Codeine (Opioids)

Dihydrocodeine (Opioids)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com